When it rains
When it rains
Stay updated with breaking news from Jay Lichter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Arialys Therapeutics Inc. launched this month with $58 million in seed funding, an experimental compound it is developing for autoimmune encephalitis and autoimmune psychosis, and high aspirations for its field. “Yes, I want to treat these patients, I want these patients to have a better life. But I also want drug discovery and development folks to think differently about discovering new drugs for the CNS,” Jay Lichter told BioWorld.
This disease can, at the very least, help researchers to “identify” the floodgates to definitive tests and therapies for complex psychological and neurological diseases, expert says.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
The San Diego Angel Conference, a program at the University of San Diego’s Knauss School of Business, is launching a fund for its sixth angel conference program.